Fortis Healthcare is currently trading at Rs. 98.75, up by 0.15 points or 0.15% from its previous closing of Rs. 98.60 on the BSE.
The scrip opened at Rs. 98.60 and has touched a high and low of Rs. 99.30 and Rs. 97.50 respectively. So far 25703 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 171.50 on 27-Jul-2011 and a 52 week low of Rs. 81.00 on 28-Dec-2011.
Last one week high and low of the scrip stood at Rs. 103.45 and Rs. 97.50 respectively. The current market cap of the company is Rs. 3980.89 crore.
The promoters holding in the company stood at 81.48% while Institutions and Non-Institutions held 5.79% and 12.73% respectively.
Fortis Healthcare, country’s second largest hospital chain is looking for the members’ approval for internal restructuring. Under the company’s internal restructuring, some of its hospitals would be separated into two business verticals.
Further, the company is planning to split its business into a ‘medical services division’ and ‘clinical establishment division’. According to the plan, the clinical establishment division will comprise radiology and out patients departments of 16 identified hospitals, including four new facilities.
Earlier, the company had announced that it is likely to raise about Rs 2,000 crore by listing its hospitals business in Singapore, through group unit Religare Health Trust. Through these funds, it aims to expand its clinical operations and cut debt. It has received in-principle approval for the listing proposal. The company aims to add about 2,500 hospital beds in 3-4 years.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: